US Drug Recall Register
Class II · Moderate risk Terminated Initiated Oct 2, 2023 (3 years ago)

Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

Recalling firm
Pine Pharmaceuticals, LLC
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0064-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lidocaine recalls

See all